University of Wisconsin Foundation

13F filer · CIK 0001697228

Reported Aug 14, 2026

Net buyer this quarter

13F portfolio value$126MU.S. long equity reported on 13F

Positions92 new · 3 closed

Net flow last quarter+$5.89MBuys minus sells

Top 10 positions weight100.0%Concentration

Holdings

13F · last 4 quarters free

Scroll for earlier quarters

Company	Value	% of portfolio	% of company	POSITION CHANGE qoq %	First reported
Q2 2026Reported Aug 14, 20269 positions
SMHMarket Vectors ETF Trust	$28.8M	22.77%	Not reported	New	Q2 2026
CBRSCerebras Systems Inc.	$18.8M	14.86%	Not reported	New	Q2 2026
PDCCPearl Diver Credit Co Inc.	$14.5M	11.51%	Not reported	Not reported	Q3 2024
PCVXVaxcyte, Inc.	$13.9M	11.03%	0.17%	Not reported	Q4 2025
NUNu Holdings Ltd.	$13.7M	10.86%	Not reported	Not reported	Q1 2023
PRAXPraxis Precision Medicines, Inc.	$11.6M	9.21%	0.12%	+37.7%	Q1 2026
AAPLApple Inc.	$9.01M	7.14%	0.00%	-26.4%	Q3 2025
GOOGLAlphabet Inc.	$8.99M	7.12%	0.00%	-29.7%	Q1 2026
DYNDyne Therapeutics, Inc.	$6.96M	5.51%	0.19%	-35.3%	Q3 2025
Q1 2026Reported May 14, 202610 positions
PDCCPearl Diver Credit Co Inc.	$15.3M	13.61%	Not reported	Not reported	Q3 2024
NUNu Holdings Ltd.	$14.8M	13.10%	Not reported	-28.3%	Q1 2023
PCVXVaxcyte, Inc.	$13.9M	12.37%	0.17%	-2.9%	Q4 2025
AAPLApple Inc.	$10.7M	9.54%	0.00%	-35.3%	Q3 2025
SESea Ltd	$10.7M	9.46%	0.07%	Not reported	Q3 2024
NVDANvidia Corp	$10.5M	9.29%	0.00%	-32.6%	Q3 2025
GOOGLAlphabet Inc.	$10.3M	9.14%	0.00%	New	Q1 2026
MSFTMicrosoft Corp	$9.57M	8.49%	0.00%	-20.3%	Q3 2025
DYNDyne Therapeutics, Inc.	$8.79M	7.80%	0.29%	+16.3%	Q3 2025
PRAXPraxis Precision Medicines, Inc.	$8.12M	7.21%	0.09%	New	Q1 2026
Q4 2025Reported Feb 13, 20268 positions
NUNu Holdings Ltd.	$24M	20.16%	Not reported	Not reported	Q1 2023
PDCCPearl Diver Credit Co Inc.	$20.3M	17.09%	Not reported	Not reported	Q3 2024
AAPLApple Inc.	$17.8M	14.96%	0.00%	+66.1%	Q3 2025
NVDANvidia Corp	$16.6M	13.97%	0.00%	+61.8%	Q3 2025
MSFTMicrosoft Corp	$15.7M	13.19%	0.00%	+66.9%	Q3 2025
PCVXVaxcyte, Inc.	$11.4M	9.58%	0.19%	New	Q4 2025
DYNDyne Therapeutics, Inc.	$8.15M	6.85%	0.25%	-19.5%	Q3 2025
JANXJanux Therapeutics, Inc.	$5M	4.20%	0.60%	New	Q4 2025
Q3 2025Reported Nov 14, 20259 positions
PDCCPearl Diver Credit Co Inc.	$24.1M	20.39%	Not reported	Not reported	Q3 2024
NUNu Holdings Ltd.	$22.9M	19.41%	Not reported	Not reported	Q1 2023
AKROAkero Therapeutics, Inc.	$15.6M	13.21%	0.41%	Not reported	Q3 2023
RNAMAvidity Biosciences, Inc.	$12.6M	10.67%	0.20%	New	Q3 2025
NVDANvidia Corp	$10.3M	8.70%	0.00%	New	Q3 2025
MSFTMicrosoft Corp	$10.1M	8.52%	0.00%	New	Q3 2025
AAPLApple Inc.	$10M	8.50%	0.00%	New	Q3 2025
DYNDyne Therapeutics, Inc.	$6.55M	5.55%	0.36%	New	Q3 2025
MDGLMadrigal Pharmaceuticals, Inc.	$5.97M	5.05%	0.06%	-73.1%	Q3 2023

Premium opens every quarter this fund has filed